Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOvoca Bio Regulatory News (OVB)

Share Price Information for Ovoca Bio (OVB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.90
Bid: 0.80
Ask: 1.00
Change: 0.00 (0.00%)
Spread: 0.20 (25.00%)
Open: 0.90
High: 0.95
Low: 0.85
Prev. Close: 0.90
OVB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

30 Sep 2013 07:00

RNS Number : 1665P
Ovoca Gold PLC
30 September 2013
 

Ovoca Gold plc ("Ovoca" or the "Company")

2013 Interim Results

 

Ovoca Gold is pleased to announce its interim financial statements and report covering the six month period from 1 January 2013 to 30 June 2013.

 

Highlights:

 

· Cash and cash equivalents and available for sale financial assets of US$31.3 million as at 30 June 2013;

· Total comprehensive loss for the period of US$18.2 million as at 30 June 2013 with the Company negatively impacted by adverse movements in its holdings of available for sale financial assets, driven by the fall in gold prices during the period;

· Completion of the disposal of the Olcha gold-silver deposit to Polymetal International plc ("Polymetal") in January 2013 for a consideration of 775,000 shares in Polymetal;

· Total dividends received amounting to US$753,000 relating to our holding of Polymetal shares; and

· Mapping and reconnaissance works continued on Stakhanovsky in preparation for the further development of the project.

 

 

Post period:

 

· Feasibility study and Resource Calculation study on our Stakhanovsky project (prepared in accordance with Russian Standards) submitted to the State Committee of Reserves for review and approval; and

· Conservation works completed both on Stakhanovsky and Rassoshinskaya sites in preparation for the winter season.

 

 

CEO's Letter

 

Dear shareholders,

 

It is my pleasure to report to you our financials and the results of our work for the first half of 2013. The first six months of this year proved to be a very challenging period not only for our Company, but for the whole mining sector. The fall in commodity prices during the period had a significant impact on the gold mining industry. We were also affected by this retreat in gold prices and recognised unrealized losses from the securities which we hold in treasury.

 

Despite that negative impact, our financial position remains strong. We duly managed our cash position and received US$544,000 from deposits, received US$753,000 in dividends through our holding of Polymetal shares and also reduced our operational expenses. Our holding of Polymetal shares increased up to a total of 1,405,000 shares due to the successful completion of the disposal of the Olcha deposit in January when we received a consideration of 775,000 Polymetal shares for the project. After taking into account the unstable market conditions during the period, we decided to focus our attention on completion of technological and analytical studies of our Stakhanovsky asset and on the preparation of feasibility and resource calculation studies (in accordance with Russian standards). These studies were completed and submitted to the State Committee of Reserves and are being reviewed now. A JORC compliant resource update report for Stakhanovsky is nearing completion and will be announced in the coming weeks. Finally, mining equipment on both of our sites has been stored, conserved and prepared for the forthcoming winter period.

 

 

Sincerely,

Kirill Golovanov

CEO

 

The financial results for the half year ended 30 June 2013 can be viewed at the following link:

http://www.rns-pdf.londonstockexchange.com/rns/1665P_-2013-9-27.pdf

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR EASNXADDDEFF
Date   Source Headline
23rd Jan 20247:00 amRNSHolding(s) in Company
1st Dec 202312:00 pmRNSResult of AGM
7th Nov 20239:15 amRNSNotice of AGM
28th Sep 20237:00 amRNSInterim Results
31st Aug 20237:00 amRNSSummary Results of Phase II Study for Orenetide
30th Jun 20237:00 amRNSAnnual Financial Report
12th Jun 20237:00 amRNSUpdate on Completion Timelines for Phase II Study
16th Mar 20234:35 pmRNSPrice Monitoring Extension
16th Mar 20232:05 pmRNSSecond Price Monitoring Extn
16th Mar 20232:00 pmRNSPrice Monitoring Extension
16th Mar 20239:05 amRNSSecond Price Monitoring Extn
16th Mar 20239:00 amRNSPrice Monitoring Extension
8th Mar 20237:00 amRNSDisposal of Russian Assets
14th Feb 20234:41 pmRNSSecond Price Monitoring Extn
14th Feb 20234:35 pmRNSPrice Monitoring Extension
14th Feb 20232:05 pmRNSSecond Price Monitoring Extn
14th Feb 20232:00 pmRNSPrice Monitoring Extension
13th Feb 20239:00 amRNSPrice Monitoring Extension
13th Jan 202311:05 amRNSSecond Price Monitoring Extn
13th Jan 202311:00 amRNSPrice Monitoring Extension
28th Oct 20227:00 amRNSResult of AGM
6th Oct 20222:30 pmRNSNotice of AGM
30th Sep 20227:00 amRNSInterim Results
29th Jul 20227:00 amRNSCompletion of Enrollment in Phase II Study
30th Jun 20227:00 amRNSAnnual Financial Report
7th Mar 20229:00 amRNSStatement re Russian Business Operations
23rd Feb 20224:41 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
22nd Feb 20223:30 pmRNSRussian Marketing Authorisation for Orenetide
31st Jan 20227:00 amRNSBoard Changes and Update
30th Dec 20217:00 amRNSDirectorate Change
4th Nov 20213:53 pmRNSHolding(s) in Company
4th Nov 20213:50 pmRNSDirector/PDMR Shareholding
4th Nov 20213:46 pmRNSBoard Change
14th Sep 20217:00 amRNSInterim Results
29th Jul 20215:00 pmRNSResult of AGM
24th Jun 20217:00 amRNSAnnual Report and Notice of AGM
10th Mar 20217:00 amRNSMigration of Participating Securities
16th Feb 20212:00 pmRNSResult of EGM
29th Jan 20217:00 amRNSFirst Patient Enrolled in Phase II Study - BP-101
25th Jan 20213:30 pmRNSNotice of EGM
5th Jan 20217:00 amRNSRe-Filing of Marketing Authorisation Application
17th Dec 20202:45 pmRNSResult of AGM
27th Nov 20203:08 pmRNSNotice of AGM
9th Oct 20207:00 amRNSAppointment of Chief Business Officer
2nd Oct 202011:06 amRNSSecond Price Monitoring Extn
2nd Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20209:05 amRNSSecond Price Monitoring Extn
2nd Oct 20209:00 amRNSPrice Monitoring Extension
2nd Oct 20207:00 amRNSUpdate re Russian Marketing Authorisation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.